Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 4, 2016, Pages 960-965

  Cheung, Sarah K C ^a,b,c   Chuang, Po Kai ^a,d   Huang, Han Wen ^a   Hwang Verslues, Wendy W ^a   Cho, Candy Hsin Hua ^a   Yang, Wen Bin ^a   Shen, Chia Ning ^a   Hsiao, Michael ^a   Hsu, Tsui Ling ^a   Chang, Chuan Fa ^d   Wong, Chi Huey ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cancer specific; Globo series; Glycolipids

Indexed keywords

BETA 1,3 GALACTOSYLTRANSFERASE; CANCER VACCINE; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; CD24 ANTIGEN; EFFECTOR CASPASE; EPITOPE; GALACTOSYLTRANSFERASE; GLYCAN; HERMES ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; B3GALT5 PROTEIN, HUMAN; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE-SPECIFIC EMBRYONIC ANTIGEN-3; TUMOR ANTIGEN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER STEM CELL; CANCER THERAPY; CARCINOGENICITY; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL SELF-RENEWAL; TUMOR GROWTH; ANIMAL; BREAST TUMOR; CHEMISTRY; FEMALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; APOPTOSIS; BASE SEQUENCE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GALACTOSYLTRANSFERASES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASTIC STEM CELLS; STAGE-SPECIFIC EMBRYONIC ANTIGENS;

EID: 84955587881     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1522602113     Document Type: Article

References (28)

1. Beck B, Blanpain C (2013) Unravelling cancer stem cell potential. Nat Rev Cancer 13(10): 727-738.
2. Bomken S, Fiser K, Heidenreich O, Vormoor J (2010) Understanding the cancer stem cell. Br J Cancer 103(4): 439-445.
3. Clarke MF, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66(19): 9339-9344.
4. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355(12): 1253-1261.
5. Pece S, et al. (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140(1): 62-73.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7): 3983-3988.
7. Ginestier C, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5): 555-567.
8. Hwang-Verslues WW, et al. (2009) Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 4(12): E8377.
9. Wright MH, et al. (2008) Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10(1): R10.
10. Fuster MM, Esko JD (2005) The sweet and sour of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer 5(7): 526-542.
11. de Leoz ML, et al. (2011) High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics 10(1): M110.002717.
12. Lau KS, Dennis JW (2008) N-glycans in cancer progression. Glycobiology 18(10): 750-760.
13. Hakomori S, Young WW (1978) Tumor-associated glycolipid antigens and modified blood group antigens. Scand J Immunol 7: 97-117.
14. Kannagi R, et al. (1983) Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2(12): 2355-2361.
15. Hakomori S (1985) Aberrant glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Res 45(6): 2405-2414.
16. Chang WW, et al. (2008) Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci USA 105(33): 11667-11672.
17. Lou YW, et al. (2014) Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers. Proc Natl Acad Sci USA 111(7): 2482-2487.
18. Wang CC, et al. (2008) Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci USA 105(33): 11661-11666.
19. Huang YL, et al. (2013) Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. Proc Natl Acad Sci USA 110(7): 2517-2522.
20. Zhou D, Henion TR, Jungalwala FB, Berger EG, Hennet T (2000) The beta 1, 3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase. J Biol Chem 275(30): 22631-22634.
21. Rajan VP, Larsen RD, Ajmera S, Ernst LK, Lowe JB (1989) A cloned human DNA restriction fragment determines expression of a GDP-L-fucose: Beta-D-galactoside 2-alpha-L-fucosyltransferase in transfected cells. Evidence for isolation and transfer of the human H blood group locus. J Biol Chem264(19): 11158-11167.
22. Rouquier S, et al. (1995) Molecular cloning of a human genomic region containing the H blood group alpha(1, 2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270(9): 4632-4639.
23. Saito S, et al. (2003) Human alpha2, 3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase. J Biol Chem 278(29): 26474-26479.
24. Shaw FL, et al. (2012) A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J Mammary Gland Biol Neoplasia 17(2): 111-117.
25. Liang C-H, et al. (2011) Effects of neighboring glycans on antibody-carbohydrate interaction. Angew Chem Int Ed Engl 50(7): 1608-1612.
26. Lingwood D, et al. (2011) Cholesterol modulates glycolipid conformation and receptor activity. Nat Chem Biol 7(5): 260-262.
27. Novak A, et al. (2013) Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies. Glycobiology 23(11): 1230-1239.
28. Danishefsky SJ, Shue YK, Chang MN, Wong CH (2015) Development of Globo-H cancer vaccine. Acc Chem Res 48(3): 643-652.